Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brook

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Molecular and Cellular Cardiology|April 1, 2017
Tropomyosin 1: Multiple roles in the developing heart and in the formation of congenital heart defectsJennifer England, Javier Granados-Riveron, Luis Polo-Parada, et al.
BMC Genetics|June 21, 2013
Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of FallotJulian Palomino Doza, Ana Topf, Jamie Bentham, et al.
Human Molecular Genetics|December 19, 2018
Transcriptome alterations in myotonic dystrophy skeletal muscle and heartEric T Wang, Daniel Treacy, Katy Eichinger, et al.
Human Molecular Genetics|November 2, 2013
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell linesAmi Ketley, Catherine Z Chen, Xin Li, et al.
Genome Medicine|August 30, 2020
Systems genetics analysis identifies calcium-signaling defects as novel cause of congenital heart diseaseJose M G Izarzugaza, Sabrina G Ellesøe, Canan Doganli, et al.
Circulation. Cardiovascular Genetics|April 17, 2012
A common variant in the PTPN11 gene contributes to the risk of tetralogy of FallotJudith A Goodship, Darroch Hall, Ana Topf, et al.
Nature Genetics|March 1, 2005
Mutation in myosin heavy chain 6 causes atrial septal defectYung-Hao Ching, Tushar K Ghosh, Steve J Cross, et al.
Plos One|March 25, 2009
Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformationHelen R Griffin, Darroch H Hall, Ana Topf, et al.
NPJ Genomic Medicine|June 2, 2026
Assessing the contribution of rare variants to congenital heart disease through a large-scale case-control exome studyEnrique Audain, Anna Wilsdon, Gregor Dombrowsky, et al.
Science Translational Medicine|May 1, 2020
CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse modelAmi Ketley, Marzena Wojciechowska, Sonja Ghidelli-Disse, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Molecular and Cellular Cardiology|April 1, 2017
Tropomyosin 1: Multiple roles in the developing heart and in the formation of congenital heart defectsJennifer England, Javier Granados-Riveron, Luis Polo-Parada, et al.
BMC Genetics|June 21, 2013
Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of FallotJulian Palomino Doza, Ana Topf, Jamie Bentham, et al.
Human Molecular Genetics|December 19, 2018
Transcriptome alterations in myotonic dystrophy skeletal muscle and heartEric T Wang, Daniel Treacy, Katy Eichinger, et al.
Human Molecular Genetics|November 2, 2013
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell linesAmi Ketley, Catherine Z Chen, Xin Li, et al.
Genome Medicine|August 30, 2020
Systems genetics analysis identifies calcium-signaling defects as novel cause of congenital heart diseaseJose M G Izarzugaza, Sabrina G Ellesøe, Canan Doganli, et al.
Circulation. Cardiovascular Genetics|April 17, 2012
A common variant in the PTPN11 gene contributes to the risk of tetralogy of FallotJudith A Goodship, Darroch Hall, Ana Topf, et al.
Nature Genetics|March 1, 2005
Mutation in myosin heavy chain 6 causes atrial septal defectYung-Hao Ching, Tushar K Ghosh, Steve J Cross, et al.
Plos One|March 25, 2009
Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformationHelen R Griffin, Darroch H Hall, Ana Topf, et al.
NPJ Genomic Medicine|June 2, 2026
Assessing the contribution of rare variants to congenital heart disease through a large-scale case-control exome studyEnrique Audain, Anna Wilsdon, Gregor Dombrowsky, et al.
Science Translational Medicine|May 1, 2020
CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse modelAmi Ketley, Marzena Wojciechowska, Sonja Ghidelli-Disse, et al.
Pageof 6